End Stage Liver Disease Cirrhosis Liver Liver Transplant Frailty end stage Liver Diseases
Lead Scientist at UCSF
- Jennifer C Lai, MD, MBA
Dr. Lai is a general and transplant hepatologist who specializes in caring for patients with chronic viral hepatitis, autoimmune disorders, and cirrhosis, particularly those awaiting liver transplantation. Her academic mission is to improve the lives of patients with end-stage liver disease through the application of core principles of geriatrics into the care of patients with cirrhosis.
- accepting new patients
- Start Date
- Completion Date
- University of California, San Francisco
- We developed a novel clinical liver frailty index, consisting of hand grip strength, timed chair stands, and balance testing, that correctly reclassifies 1 in 5 patients to their accurate survival status, compared to MELDNa alone.
- Study Type
- Last Updated